Search in:

OncoTargets and Therapy Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Sylvia Guetz1 Ev. Diakonissenkrankenhaus Leipzig, Leipzig

Amanda Tufman2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), Munich

Joachim von Pawel3 Asklepios Fachkliniken Muenchen-Gauting, Gauting

Achim Rittmeyer4 Lungenfachklinik Immenhausen, Immenhausen, Germany

Astrid Borgmeier2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), Munich

Pierre Ferré5 Pierre Fabre Pharmaceuticals, Oncology Research and Development Center, Toulouse, France

Birgit Edlich6 Pierre Fabre Pharma GmbH, Freiburg, Germany

Rudolf Maria Huber2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), MunichCorrespondence[email protected]

show all

Pages 1081-1089 | Published online: 21 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Fernanda Estevinho, Rita Gomes, Direndra Hasmucrai & Fernando Barata. (2022) Metronomic oral vinorelbine in a real-world population of advanced non-small cell lung cancer patients. Pulmonology 28:5, pages 368-375.
Crossref

Fabrice Barlesi, Laure Deyme, Diane-Charlotte Imbs, Elissa Cousin, Mathieu Barbolosi, Sylvanie Bonnet, Pascale Tomasini, Laurent Greillier, Melissa Galloux, Albane Testot-Ferry, Annick Pelletier, Nicolas André, Joseph Ciccolini & Dominique Barbolosi. (2022) Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer. Cancer Chemotherapy and Pharmacology 90:2, pages 149-160.
Crossref

Slavomir Krajnak, Thomas Decker, Lukas Schollenberger, Christian Rosé, Christian Ruckes, Tanja Fehm, Christoph Thomssen, Nadia Harbeck & Marcus Schmidt. (2021) Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046. Journal of Cancer Research and Clinical Oncology 147:11, pages 3391-3400.
Crossref

A. Camerini, A. Morabito, A. Montanino, R. Bernabé, F. Grossi, R. Ramlau, T.-E. Ciuleanu, G.-L. Ceresoli, G. Pasello, F. de Marinis, J. Bosch-Barrera, P. Laundreau, S. Gautier, C. Ta Thanh Minh & D. Kowalski. (2021) Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial. ESMO Open 6:2, pages 100051.
Crossref

Maria Kandi, Peter Meldgaard & Marianne Marquard Knap. (2021) Metronomic oral vinorelbine doublet chemotherapy with carboplatin in treatment of advanced lung cancer: a feasibility and safety study. F1000Research 10, pages 673.
Crossref

Ke Xu, Tao Liu, Jie Zhang, Yangang Zhou, Fang Yang & Tao Ren. (2020) The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis. International Journal of Clinical Oncology 25:9, pages 1624-1634.
Crossref

Alain Vergnenegre, Isabelle Monnet, Acya Bizieux, Marie Bernardi, Anne Marie Chiapa, Hervé Léna, Christos Chouaïd & Gilles Robinet. (2020) Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine–atezolizumab combination for stage-IV non-small-cell lung cancer – VinMetAtezo trial, (GFPC ‡ 04-2017) . Future Oncology 16:4, pages 5-10.
Crossref

Jean-Louis Pujol, Amandine Coffy, Andrea Camerini, Athanasios Kotsakis, Manlio Mencoboni, Milena Gusella, Felice Pasini, Aldo Pezzuto, Giuseppe Luigi Banna, Cemil Bilir, Epaminontas Samantas, Fabrice Barlesi, Benoît Roch, Aude Guillou & Jean-Pierre Daurès. (2019) An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer. PLOS ONE 14:8, pages e0220988.
Crossref

Sven Tyge Langkjer, Julia Kenholm, Jeanette Dupont Jensen, Kim Wedervang, Annette Torbøl Brixen, Mie Grunnet, Lars Stenbygaard, Bjørnar Gilje, Hella Danø, Vesna Glavicic, Erik Hugger Jacobsen, Anne Sofie Brems-Eskildsen, Helle Lemvig Kruse, Trine Dongsgaard, Jeppe Neimann & Jürgen Geisler. (2019) The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. Future Oncology 15:22, pages 2561-2569.
Crossref

Milena Gusella, Felice Pasini, Donatella Caruso, Carmen Barile, Yasmina Modena, Anna Paola Fraccon, Laura Bertolaso, Daniela Menon, Giorgio Crepaldi, Antonio Bononi, Roberto Spezzano, Giorgia Anna Telatin, Giuseppe Corona & Roberto Padrini. (2018) Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms. Cancer Chemotherapy and Pharmacology 83:3, pages 493-500.
Crossref

Felice Pasini, Carmen Barile, Donatella Caruso, Yasmina Modena, Anna Paola Fraccon, Laura Bertolaso, Daniela Menon, Francesca La Russa, Giorgio Crepaldi, Antonio Bononi, Roberto Spezzano, Roberto Padrini, Giuseppe Corona & Milena Gusella. (2018) Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world. Investigational New Drugs 36:5, pages 927-932.
Crossref

Michela D’Ascanio, Aldo Pezzuto, Chiara Fiorentino, Bruno Sposato, Pierdonato Bruno, Alessio Grieco, Rita Mancini & Alberto Ricci. (2018) Metronomic Chemotherapy with Vinorelbine Produces Clinical Benefit and Low Toxicity in Frail Elderly Patients Affected by Advanced Non-Small Cell Lung Cancer. BioMed Research International 2018, pages 1-6.
Crossref

Paola Orlandi, Teresa Di Desidero, Giada Salvia, Beatrice Muscatello, Giulio Francia & Guido Bocci. (2018) Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors. Biochemical Pharmacology 152, pages 327-337.
Crossref

María José Vallejo, Lizeth Salazar & Marcelo Grijalva. (2017) Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on In Vitro Models for Plant-Derived Compounds . Oxidative Medicine and Cellular Longevity 2017, pages 1-9.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date